Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

buthionine sulfoximine

A synthetic amino acid. Buthionine sulfoximine irreversibly inhibits gamma-glutamylcysteine synthase, thereby depleting cells of glutathione, a metabolite that plays a critical role in protecting cells against oxidative stress, and resulting in free radical-induced apoptosis. Elevated glutathione levels are associated with tumor cell resistance to alkylating agents and platinum compounds. By depleting cells of glutathione, this agent may enhance the in vitro and in vivo cytotoxicities of various chemotherapeutic agents in drug-resistant tumors. Buthionine sulfoximine may also exhibit antiangiogenesis activity.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:L-buthionine sulfoximine
Abbreviation:BSO
Chemical structure:2-amino-4-(S-butylsulfonimidoyl) butanoic acid
butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-
S-(3-amino-3-carboxypropyl)-S-butylsulfoximine
S-(n-butyl)homocysteine sulfoximine
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search